Cercosporin

Cercosporin

SCHEMBL21175561

COc1c(C[C@@H](C)O)c2c3c(C[C@@H](C)O)c(OC)c(=O)c4c(O)cc5c(c6c(cc(O)c(c1=O)c62)OCO5)c43.C[S+](C)[O-]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MAP2K1MAP2K2

The experimentally established mechanism targets of Cercosporin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TCF4 P15884 4/20 0.65
CTNNB1 P35222 4/20 0.65
CDH1 P12830 1/20 0.65
APC P25054 1/20 0.65
TCF7L2 Q9NQB0 1/20 0.65
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
HDAC1 Q13547 1/20 0.32
P4HB P07237 3/20 0.31
SMPD1 P17405 1/20 0.31
CDK2 P24941 2/20 0.31
SMAD3 P84022 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cercosporin SCHEMBL6305985 0.94 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL498747 0.94 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL29613349 0.94 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL15185706 0.94 TCF4 (0.71) TCF4CTNNB1CDH1APCTCF7L2
Cercosporin SCHEMBL28102616 0.93 TCF4 (0.70) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL22930428 0.88 TCF4 (0.64) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL29369377 0.79 CTNNB1 (1.00) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL13121634 0.77 CTNNB1 (0.49) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL8476647 0.68 TCF4 (0.42) TCF4CTNNB1CDH1APCTCF7L2
SCHEMBL29711267 0.62 CTNNB1 (0.68) TCF4CTNNB1CDH1APCTCF7L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11359044-B2 Preparation and application of novel multifunctional nanocomposite material with new photosensitizer JIANGNAN UNIVERSITY (CN) 2022-06-14 US disclosed
CN-106267249-B Application of radioisotope-labeled perylenequinones in preparation of necrotic myocardial imaging agent 中国药科大学 2020-01-31 CN disclosed
US-20190224318-A1 Preparation and Application of Novel Multifunctional Nanocomposite Material with new Photosensitizer JIANGNAN UNIVERSITY (CN) 2019-07-25 US disclosed
CN-108187068-B A kind of preparation and its application of photosensitizer composite Nano multifunctional material 江南大学 2019-04-23 CN disclosed
CN-108187068-A A kind of preparation and its application of novel photosensitive agent composite Nano multifunctional material 江南大学 2018-06-22 CN disclosed
CN-106267249-A The application in preparing necrotic myocardium developer of the labelled with radioisotope quinones 中国药科大学 2017-01-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190224318-A1 Preparation and Application of Novel Multifunctional Nanocomposite Material with new Photosensitizer GPI, GYPA, FUT6 TCF4 4882/4885CTNNB1 3425/4885CDH1 2016/4885
US-11359044-B2 Preparation and application of novel multifunctional nanocomposite material with new photosensitizer GPI, GYPA, FUT6 TCF4 4882/4885CTNNB1 3425/4885CDH1 2016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.